Usefulness of immunomodulators for long-term prognosis of Crohn's disease

Makoto Naganuma, Toshimitsu Fujii, Masakazu Nagahori, Mamoru Watanabe

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)388-400
Number of pages13
JournalJournal of Japanese Society of Gastroenterology
Volume108
Issue number3
Publication statusPublished - 2011 Mar
Externally publishedYes

Fingerprint

Immunologic Factors
Crohn Disease

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Usefulness of immunomodulators for long-term prognosis of Crohn's disease. / Naganuma, Makoto; Fujii, Toshimitsu; Nagahori, Masakazu; Watanabe, Mamoru.

In: Journal of Japanese Society of Gastroenterology, Vol. 108, No. 3, 03.2011, p. 388-400.

Research output: Contribution to journalArticle

Naganuma, Makoto ; Fujii, Toshimitsu ; Nagahori, Masakazu ; Watanabe, Mamoru. / Usefulness of immunomodulators for long-term prognosis of Crohn's disease. In: Journal of Japanese Society of Gastroenterology. 2011 ; Vol. 108, No. 3. pp. 388-400.
@article{22d0ba87fffd42558963208edb7dca2a,
title = "Usefulness of immunomodulators for long-term prognosis of Crohn's disease",
author = "Makoto Naganuma and Toshimitsu Fujii and Masakazu Nagahori and Mamoru Watanabe",
year = "2011",
month = "3",
language = "English",
volume = "108",
pages = "388--400",
journal = "Journal of Japanese Society of Gastroenterology",
issn = "0446-6586",
publisher = "Japanese Society of Gastroenterology",
number = "3",

}

TY - JOUR

T1 - Usefulness of immunomodulators for long-term prognosis of Crohn's disease

AU - Naganuma, Makoto

AU - Fujii, Toshimitsu

AU - Nagahori, Masakazu

AU - Watanabe, Mamoru

PY - 2011/3

Y1 - 2011/3

UR - http://www.scopus.com/inward/record.url?scp=79954459848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954459848&partnerID=8YFLogxK

M3 - Article

VL - 108

SP - 388

EP - 400

JO - Journal of Japanese Society of Gastroenterology

JF - Journal of Japanese Society of Gastroenterology

SN - 0446-6586

IS - 3

ER -